{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T05:29:55Z","timestamp":1772774995273,"version":"3.50.1"},"reference-count":230,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T00:00:00Z","timestamp":1614384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T00:00:00Z","timestamp":1614384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Immunol. Ther. Exp."],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s00005-021-00604-x","type":"journal-article","created":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T08:02:25Z","timestamp":1614412945000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Cancer Immunoprevention: Current Status and Future Directions"],"prefix":"10.2478","volume":"69","author":[{"given":"Mahsa","family":"Keshavarz-Fathi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3836-1827","authenticated-orcid":false,"given":"Nima","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2021,2,27]]},"reference":[{"key":"604_CR1","first-page":"1645","volume":"54","author":"LA Aaltonen","year":"1994","unstructured":"Aaltonen LA, Peltom\u00e4ki P, Mecklin JP et al (1994) Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res 54:1645\u20131648","journal-title":"Cancer Res"},{"key":"604_CR2","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00262-011-1005-7","volume":"60","author":"S Adams","year":"2011","unstructured":"Adams S, Greeder L, Reich E et al (2011) Expression of cancer testis antigens in human BRCA-associated breast cancers: potential targets for immunoprevention? Cancer Immunol Immunother 60:999\u20131007","journal-title":"Cancer Immunol Immunother"},{"key":"604_CR3","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3892\/ol.2016.4672","volume":"12","author":"K Al-Khayal","year":"2016","unstructured":"Al-Khayal K, Abdulla M, Al-Obaid O et al (2016) Differential expression of mucins in Middle Eastern patients with colorectal cancer. Oncol Lett 12:393\u2013400","journal-title":"Oncol Lett"},{"key":"604_CR4","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/jso.2930280316","volume":"28","author":"C Amanti","year":"1985","unstructured":"Amanti C, Midiri G, Benedetti M et al (1985) Tissue CEA detection by immunoperoxidase (PAP) test in colorectal polyps: correlations with the degree of dysplasia. J Surg Oncol 28:222\u2013226","journal-title":"J Surg Oncol"},{"key":"604_CR5","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3324\/haematol.2009.014464","volume":"95","author":"D Atanackovic","year":"2010","unstructured":"Atanackovic D, Hildebrandt Y, Jadczak A et al (2010) Cancer-testis antigens MAGE-C1\/CT7 and MAGE-A3 promote the survival of multiple myeloma cells. Haematologica 95:785\u2013793","journal-title":"Haematologica"},{"key":"604_CR6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ijc.11681","volume":"109","author":"D Atkins","year":"2004","unstructured":"Atkins D, Breuckmann A, Schmahl GE et al (2004) MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma. Int J Cancer 109:265\u2013273","journal-title":"Int J Cancer"},{"key":"604_CR7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0002-9610(86)90012-7","volume":"151","author":"FC Au","year":"1986","unstructured":"Au FC, Stein B, Tang CK (1986) Carcinoembryonic antigen levels in colonic lesions. Am J Surg 151:61\u201364","journal-title":"Am J Surg"},{"key":"604_CR8","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.1158\/1078-0432.CCR-11-2776","volume":"18","author":"J Bae","year":"2012","unstructured":"Bae J, Smith R, Daley J et al (2012) Myeloma-specific multiple peptides able to generate cytotoxic T lymphocytes: a potential therapeutic application in multiple myeloma and other plasma cell disorders. Clin Cancer Res 18:4850\u20134860","journal-title":"Clin Cancer Res"},{"key":"604_CR9","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/leu.2014.159","volume":"29","author":"J Bae","year":"2015","unstructured":"Bae J, Prabhala R, Voskertchian A et al (2015) A multiepitope of XBP1, CD138 and CS1 peptides induces myeloma-specific cytotoxic T lymphocytes in T cells of smoldering myeloma patients. Leukemia 29:218\u2013229","journal-title":"Leukemia"},{"key":"604_CR10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1034\/j.1600-0714.2003.00167.x","volume":"32","author":"JV Bagan","year":"2003","unstructured":"Bagan JV, Jimenez Y, Sanchis JM et al (2003) Proliferative verrucous leukoplakia: high incidence of gingival squamous cell carcinoma. J Oral Pathol Med 32:379\u2013382","journal-title":"J Oral Pathol Med"},{"key":"604_CR11","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.1158\/1078-0432.CCR-16-2540","volume":"23","author":"J Beane","year":"2017","unstructured":"Beane J, Mazzilli SA, Tassinari AM et al (2017) Detecting the presence and progression of premalignant lung lesions via airway gene expression. Clin Cancer Res 23:5091\u20135100","journal-title":"Clin Cancer Res"},{"key":"604_CR12","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1158\/1078-0432.CCR-14-1860","volume":"21","author":"GL Beatty","year":"2015","unstructured":"Beatty GL, Gladney WL (2015) Immune escape mechanisms as a guide for cancer immunotherapy. Clin Cancer Res 21:687\u2013692","journal-title":"Clin Cancer Res"},{"key":"604_CR13","first-page":"488","volume":"23","author":"S Bhatia","year":"2009","unstructured":"Bhatia S, Tykodi SS, Thompson JA (2009) Treatment of metastatic melanoma: an overview. Oncology 23:488\u2013496","journal-title":"Oncology"},{"key":"604_CR14","first-page":"941","volume":"26","author":"G Bianchi","year":"2011","unstructured":"Bianchi G, Borgonovo G, Pistoia V et al (2011) Immunosuppressive cells and tumour microenvironment: focus on mesenchymal stem cells and myeloid derived suppressor cells. Histol Histopathol 26:941\u2013951","journal-title":"Histol Histopathol"},{"key":"604_CR15","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jaad.2006.05.048","volume":"55","author":"DR Bickers","year":"2006","unstructured":"Bickers DR, Lim HW, Margolis D et al (2006) The burden of skin diseases: 2004: a joint project of the American Academy of Dermatology Association and the Society for investigative dermatology. J Am Acad Dermatol 55:490\u2013500","journal-title":"J Am Acad Dermatol"},{"key":"604_CR16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ijc.21775","volume":"119","author":"C Blank","year":"2006","unstructured":"Blank C, Kuball J, Voelkl S et al (2006) Blockade of PD-L1 (B7\u2013H1) augments human tumor-specific T cell responses in vitro. Int J Cancer 119:317\u2013327","journal-title":"Int J Cancer"},{"key":"604_CR17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40902-018-0156-2","volume":"40","author":"GP Bombeccari","year":"2018","unstructured":"Bombeccari GP, Garagiola U, Candotto V et al (2018) Diode laser surgery in the treatment of oral proliferative verrucous leukoplakia associated with HPV-16 infection. Maxillofacial Plastic Reconstr Surg 40:16","journal-title":"Maxillofacial Plastic Reconstr Surg"},{"key":"604_CR18","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin 68:394\u2013424","journal-title":"Cancer J Clin"},{"key":"604_CR19","doi-asserted-by":"crossref","unstructured":"Brisson M, Kim JJ, Canfell K et al (2020) Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet 395:575\u2013590","DOI":"10.1016\/S0140-6736(20)30068-4"},{"key":"604_CR20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.virol.2013.05.038","volume":"445","author":"CB Buck","year":"2013","unstructured":"Buck CB, Day PM, Trus BL (2013) The papillomavirus major capsid protein L1. Virology 445:169\u2013174","journal-title":"Virology"},{"key":"604_CR21","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1055\/s-2005-916284","volume":"18","author":"WD Buie","year":"2005","unstructured":"Buie WD, Attard JAP (2005) Follow-up recommendations for colon cancer. Clin Colon Rectal Surg 18:232\u2013243","journal-title":"Clin Colon Rectal Surg"},{"key":"604_CR22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2174\/138920209787581235","volume":"10","author":"A Buitrago-P\u00e9rez","year":"2009","unstructured":"Buitrago-P\u00e9rez A, Garaulet G, V\u00e1zquez-Carballo A et al (2009) Molecular signature of HPV-induced carcinogenesis: pRb, p53 and gene expression profiling. Curr Genomics 10:26\u201334","journal-title":"Curr Genomics"},{"key":"604_CR23","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/bmj.1.5023.841","volume":"1","author":"M Burnet","year":"1957","unstructured":"Burnet M (1957) Cancer: a biological approach. III. Viruses associated with neoplastic conditions IV Practical applications. Br Med J 1:841\u2013847","journal-title":"Br Med J"},{"key":"604_CR24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-065X.1971.tb00461.x","volume":"7","author":"FM Burnet","year":"1971","unstructured":"Burnet FM (1971) Immunological surveillance in neoplasia. Immunol Rev 7:3\u201325","journal-title":"Immunol Rev"},{"key":"604_CR25","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.bjorl.2016.12.005","volume":"83","author":"DL Capella","year":"2017","unstructured":"Capella DL, Gon\u00e7alves JM, Abrantes AAA et al (2017) Proliferative verrucous leukoplakia: diagnosis, management and current advances. Braz J Otorhinolaryngol 83:585\u2013593","journal-title":"Braz J Otorhinolaryngol"},{"key":"604_CR26","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1038\/sj.bjc.6601881","volume":"90","author":"J Carlsson","year":"2004","unstructured":"Carlsson J, Nordgren H, Sj\u00f6str\u00f6m J et al (2004) HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review. Br J Cancer 90:2344\u20132348","journal-title":"Br J Cancer"},{"key":"604_CR27","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nrc2208","volume":"7","author":"F Cavallo","year":"2007","unstructured":"Cavallo F, Calogero RA, Forni G (2007) Are oncoantigens suitable targets for anti-tumour therapy? Nat Rev Cancer 7:707\u2013713","journal-title":"Nat Rev Cancer"},{"key":"604_CR28","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1126\/science.7997879","volume":"266","author":"Y Chang","year":"1994","unstructured":"Chang Y, Cesarman E, Pessin MS et al (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi\u2019s sarcoma. Science 266:1865\u20131869","journal-title":"Science"},{"key":"604_CR29","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM199706263362602","volume":"336","author":"MH Chang","year":"1997","unstructured":"Chang MH, Chen CJ, Lai MS et al (1997) Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 336:1855\u20131859","journal-title":"N Engl J Med"},{"key":"604_CR30","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1007\/s00784-018-2622-8","volume":"23","author":"ALF Chaves","year":"2019","unstructured":"Chaves ALF, Silva AG, Maia FM et al (2019) Reduced CD8(+) T cells infiltration can be associated to a malignant transformation in potentially malignant oral epithelial lesions. Clin Oral Investig 23:1913\u20131919","journal-title":"Clin Oral Investig"},{"key":"604_CR31","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1158\/2326-6066.CIR-13-0124","volume":"2","author":"YT Chen","year":"2014","unstructured":"Chen YT, Panarelli NC, Piotti KC et al (2014) Cancer-testis antigen expression in digestive tract carcinomas: frequent expression in esophageal squamous cell carcinoma and its precursor lesions. Cancer Immunol Res 2:480\u2013486","journal-title":"Cancer Immunol Res"},{"key":"604_CR32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.addr.2014.09.001","volume":"81","author":"G Cheng","year":"2015","unstructured":"Cheng G (2015) Circulating miRNAs: roles in cancer diagnosis, prognosis and therapy. Adv Drug Deliv Rev 81:75\u201393","journal-title":"Adv Drug Deliv Rev"},{"key":"604_CR33","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/cncr.11857","volume":"99","author":"DC Chhieng","year":"2003","unstructured":"Chhieng DC, Benson E, Eltoum I et al (2003) MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration. Cancer 99:365\u2013371","journal-title":"Cancer"},{"key":"604_CR34","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.smim.2010.02.004","volume":"22","author":"CLL Chiang","year":"2010","unstructured":"Chiang CLL, Benencia F, Coukos G (2010) Whole tumor antigen vaccines. Semin Immunol 22:132\u2013143","journal-title":"Semin Immunol"},{"key":"604_CR35","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0006-291X(03)01121-5","volume":"307","author":"B Cho","year":"2003","unstructured":"Cho B, Lee H, Jeong S et al (2003) Promoter hypomethylation of a novel cancer\/testis antigen gene CAGE is correlated with its aberrant expression and is seen in premalignant stage of gastric carcinoma. Biochem Biophys Res Commun 307:52\u201363","journal-title":"Biochem Biophys Res Commun"},{"key":"604_CR36","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1158\/1078-0432.CCR-14-1186","volume":"21","author":"NJ Chu","year":"2015","unstructured":"Chu NJ, Armstrong TD, Jaffee EM (2015) Nonviral oncogenic antigens and the inflammatory signals driving early cancer development as targets for cancer immunoprevention. Clin Cancer Res 21:1549\u20131557","journal-title":"Clin Cancer Res"},{"key":"604_CR37","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00000658-189112000-00015","volume":"14","author":"WB Coley","year":"1891","unstructured":"Coley WB (1891) II. Contribution to the knowledge of sarcoma. Ann Surg 14:199\u2013220","journal-title":"Ann Surg"},{"key":"604_CR38","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.cgh.2012.09.010","volume":"11","author":"DA Corley","year":"2013","unstructured":"Corley DA, Jensen CD, Marks AR et al (2013) Variation of adenoma prevalence by age, sex, race, and colon location in a large population: implications for screening and quality programs. Clin Gastroenterol Hepatol 11:172\u2013180","journal-title":"Clin Gastroenterol Hepatol"},{"key":"604_CR39","doi-asserted-by":"crossref","first-page":"380","DOI":"10.4049\/jimmunol.163.1.380","volume":"163","author":"LG Corral","year":"1999","unstructured":"Corral LG, Haslett PA, Muller GW et al (1999) Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha. J Immunol 163:380\u2013386","journal-title":"J Immunol"},{"key":"604_CR40","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1172\/JCI89820","volume":"127","author":"TJ Cunningham","year":"2017","unstructured":"Cunningham TJ, Tabacchi M, Eliane JP et al (2017) Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy. J Clin Invest 127:106\u2013116","journal-title":"J Clin Invest"},{"key":"604_CR41","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1158\/0008-5472.CAN-06-4038","volume":"67","author":"BJ Czerniecki","year":"2007","unstructured":"Czerniecki BJ, Koski GK, Koldovsky U et al (2007) Targeting HER-2\/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion. Cancer Res 67:1842\u20131852","journal-title":"Cancer Res"},{"key":"604_CR42","doi-asserted-by":"crossref","first-page":"E323","DOI":"10.1073\/pnas.1101892108","volume":"108","author":"A Dalet","year":"2011","unstructured":"Dalet A, Robbins PF, Stroobant V et al (2011) An antigenic peptide produced by reverse splicing and double asparagine deamidation. Proc Natl Acad Sci USA 108:E323\u2013E331","journal-title":"Proc Natl Acad Sci USA"},{"key":"604_CR43","doi-asserted-by":"crossref","first-page":"9705","DOI":"10.1038\/s41598-020-66257-6","volume":"10","author":"K Dave","year":"2020","unstructured":"Dave K, Ali A, Magalhaes M (2020) Increased expression of PD-1 and PD-L1 in oral lesions progressing to oral squamous cell carcinoma: a pilot study. Sci Rep 10:9705","journal-title":"Sci Rep"},{"key":"604_CR44","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1182\/blood.V98.1.210","volume":"98","author":"FE Davies","year":"2001","unstructured":"Davies FE, Raje N, Hideshima T et al (2001) Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma. Blood 98:210\u2013216","journal-title":"Blood"},{"key":"604_CR45","unstructured":"Davis T (2013) Development of MUC1 vaccine for the prevention of pancreatic cancer. Retrieved Dec 9, 2020, from https:\/\/projectreporter.nih.gov\/project_info_description.cfm?aid=8760420"},{"key":"604_CR46","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00262-012-1292-7","volume":"61","author":"PJ de Vos van Steenwijk","year":"2012","unstructured":"de Vos van Steenwijk PJ, RamwadhdoebeLowik THMJ et al (2012) A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions. Cancer Immunol Immunother 61:1485\u20131492","journal-title":"Cancer Immunol Immunother"},{"key":"604_CR47","doi-asserted-by":"crossref","unstructured":"de Vos van Steenwijk PJ, van Poelgeest MI, Ramwadhdoebe TH et al (2014) The long-term immune response after HPV16 peptide vaccination in women with low-grade pre-malignant disorders of the uterine cervix: a placebo-controlled phase II study. Cancer Immunol Immunother 63:147\u2013160","DOI":"10.1007\/s00262-013-1499-2"},{"key":"604_CR48","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1470-2045(12)70137-7","volume":"13","author":"C de Martel","year":"2012","unstructured":"de Martel C, Ferlay J, Franceschi S et al (2012) Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 13:607\u2013615","journal-title":"Lancet Oncol"},{"key":"604_CR49","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1016\/j.ejca.2013.06.033","volume":"49","author":"S De Sanjos\u00e9","year":"2013","unstructured":"De Sanjos\u00e9 S, Alemany L, Ordi J et al (2013) Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva. Eur J Cancer 49:3450\u20133461","journal-title":"Eur J Cancer"},{"key":"604_CR50","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.suc.2012.12.005","volume":"93","author":"AC Degnim","year":"2013","unstructured":"Degnim AC, King TA (2013) Surgical management of high-risk breast lesions. Surg Clin North Am 93:329\u2013340","journal-title":"Surg Clin North Am"},{"key":"604_CR51","first-page":"241","volume":"76","author":"JQ Del Rosso","year":"2005","unstructured":"Del Rosso JQ (2005) The use of topical imiquimod for the treatment of actinic keratosis: a status report. Cutis 76:241\u2013248","journal-title":"Cutis"},{"issue":"9 Suppl","key":"604_CR52","first-page":"S2","volume":"7","author":"JQ Del Rosso","year":"2014","unstructured":"Del Rosso JQ, Kircik L, Goldenberg G et al (2014) Comprehensive management of actinic keratoses: practical integration of available therapies with a review of a newer treatment approach. J Clin Aesthet Dermatol 7(9 Suppl):S2\u2013S12","journal-title":"J Clin Aesthet Dermatol"},{"key":"604_CR53","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1084\/jem.20021650","volume":"197","author":"MV Dhodapkar","year":"2003","unstructured":"Dhodapkar MV, Geller MD, Chang DH et al (2003) A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma. J Exp Med 197:1667\u20131676","journal-title":"J Exp Med"},{"key":"604_CR54","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1182\/blood-2015-03-632919","volume":"126","author":"MV Dhodapkar","year":"2015","unstructured":"Dhodapkar MV, Sexton R, Das R et al (2015) Prospective analysis of antigen-specific immunity, stem-cell antigens, and immune checkpoints in monoclonal gammopathy. Blood 126:2475\u20132478","journal-title":"Blood"},{"key":"604_CR55","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1084\/jem.20101158","volume":"208","author":"MS Diamond","year":"2011","unstructured":"Diamond MS, Kinder M, Matsushita H et al (2011) Type I interferon is selectively required by dendritic cells for immune rejection of tumors. J Exp Med 208:1989\u20132003","journal-title":"J Exp Med"},{"issue":"1","key":"604_CR56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-4-1","volume":"4","author":"RS DiPaola","year":"2006","unstructured":"DiPaola RS, Plante M, Kaufman H et al (2006) A phase I trial of Pox PSA vaccines (PROSTVAC\u00ae-VF) with B7\u20131, ICAM-1, and LFA-3 co-stimulatory molecules (TRICOMTM) in patients with prostate cancer. J Transl Med 4(1):1","journal-title":"J Transl Med"},{"key":"604_CR57","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1158\/1940-6207.CAPR-13-0182","volume":"6","author":"ML Disis","year":"2013","unstructured":"Disis ML, Gad E, Herendeen DR et al (2013) A multiantigen vaccine targeting neu, IGFBP-2, and IGF-IR prevents tumor progression in mice with preinvasive breast disease. Cancer Prev Res 6:1273\u20131282","journal-title":"Cancer Prev Res"},{"key":"604_CR58","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm730","volume":"8","author":"H Dong","year":"2002","unstructured":"Dong H, Strome SE, Salomao DR et al (2002) Tumor-associated B7\u2013H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med 8:793\u2013800","journal-title":"Nat Med"},{"issue":"Suppl 13","key":"604_CR59","doi-asserted-by":"crossref","first-page":"S1581","DOI":"10.21037\/jtd.2018.02.79","volume":"10","author":"C Donini","year":"2018","unstructured":"Donini C, D\u2019Ambrosio L, Grignani G et al (2018) Next generation immune-checkpoints for cancer therapy. J Thorac Dis 10(Suppl 13):S1581\u2013S1601","journal-title":"J Thorac Dis"},{"key":"604_CR60","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(19)30298-3","volume":"394","author":"M Drolet","year":"2019","unstructured":"Drolet M, B\u00e9nard \u00c9, P\u00e9rez N et al (2019) Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. Lancet 394:497\u2013509","journal-title":"Lancet"},{"key":"604_CR61","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.trecan.2016.11.003","volume":"2","author":"BK Dunn","year":"2016","unstructured":"Dunn BK, Kramer BS (2016) Cancer prevention: lessons learned and future directions. Trends Cancer 2:713\u2013722","journal-title":"Trends Cancer"},{"key":"604_CR62","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.immuni.2004.07.017","volume":"21","author":"GP Dunn","year":"2004","unstructured":"Dunn GP, Old LJ, Schreiber RD (2004) The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21:137\u2013148","journal-title":"Immunity"},{"key":"604_CR63","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1001\/jama.2016.13645","volume":"316","author":"LAARW Dwyer-LindgrenBertozzi-Villa Stubbs","year":"2016","unstructured":"Dwyer-LindgrenBertozzi-Villa Stubbs LAARW et al (2016) US County-level trends in mortality rates for major causes of death, 1980\u20132014. JAMA 316:2385\u20132401","journal-title":"JAMA"},{"key":"604_CR64","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1034\/j.1600-065X.2002.18812.x","volume":"188","author":"VH Engelhard","year":"2002","unstructured":"Engelhard VH, Bullock TN, Colella TA et al (2002) Antigens derived from melanocyte differentiation proteins: self-tolerance, autoimmunity, and use for cancer immunotherapy. Immunol Rev 188:136\u2013146","journal-title":"Immunol Rev"},{"key":"604_CR65","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/jnci\/94.20.1546","volume":"94","author":"VL Ernster","year":"2002","unstructured":"Ernster VL, Ballard-Barbash R, Barlow WE et al (2002) Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 94:1546\u20131554","journal-title":"J Natl Cancer Inst"},{"key":"604_CR66","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-11-3687","volume":"72","author":"A Facciabene","year":"2012","unstructured":"Facciabene A, Motz GT, Coukos G (2012) T-regulatory cells: key players in tumor immune escape and angiogenesis. Cancer Res 72:2162\u20132171","journal-title":"Cancer Res"},{"key":"604_CR67","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/cmi.2013.59","volume":"11","author":"H Fang","year":"2014","unstructured":"Fang H, Ang B, Xu X et al (2014) TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells. Cell Mol Immunol 11:150\u2013159","journal-title":"Cell Mol Immunol"},{"key":"604_CR68","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1365-2893.2007.00878.x","volume":"14","author":"F Farinati","year":"2007","unstructured":"Farinati F, Cardin R, Bortolami M et al (2007) Hepatitis C virus: from oxygen free radicals to hepatocellular carcinoma. J Viral Hepat 14:821\u2013829","journal-title":"J Viral Hepat"},{"key":"604_CR69","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.smim.2010.03.003","volume":"22","author":"AM Farkas","year":"2010","unstructured":"Farkas AM, Finn OJ (2010) Vaccines based on abnormal self-antigens as tumor-associated antigens: immune regulation. Semin Immunol 22:125\u2013131","journal-title":"Semin Immunol"},{"key":"604_CR70","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s40487-020-00117-1","volume":"8","author":"NE Farrow","year":"2020","unstructured":"Farrow NE, Turner MC, Salama AKS et al (2020) Overall survival improved for contemporary patients with melanoma: a 2004\u20132015 national cancer database analysis. Oncol Ther 8:261\u2013275","journal-title":"Oncol Ther"},{"key":"604_CR71","unstructured":"FDA (2010) https:\/\/www.fda.gov\/media\/80843\/download. Retrieved Sep 02, 2020"},{"key":"604_CR72","unstructured":"FDA (2011) https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/022483s002lbl.pdf. Retrieved Sep 02, 2020"},{"key":"604_CR73","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1126\/science.1152586","volume":"319","author":"H Feng","year":"2008","unstructured":"Feng H, Shuda M, Chang Y et al (2008) Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319:1096\u20131100","journal-title":"Science"},{"key":"604_CR74","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3389\/fimmu.2012.00299","volume":"3","author":"L Fern\u00e1ndez-Messina","year":"2012","unstructured":"Fern\u00e1ndez-Messina L, Reyburn HT, Val\u00e9s-G\u00f3mez M (2012) Human NKG2D-ligands: cell biology strategies to ensure immune recognition. Front Immunol 3:299\u2013299","journal-title":"Front Immunol"},{"key":"604_CR75","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0093-7754(01)90133-2","volume":"28","author":"B Fisher","year":"2001","unstructured":"Fisher B, Land S, Mamounas E et al (2001) Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience. Semin Oncol 28:400\u2013418","journal-title":"Semin Oncol"},{"key":"604_CR76","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1245\/s10434-013-3119-y","volume":"20","author":"M Fracol","year":"2013","unstructured":"Fracol M, Xu S, Mick R et al (2013) Response to HER-2 pulsed DC1 vaccines is predicted by both HER-2 and estrogen receptor expression in DCIS. Ann Surg Oncol 20:3233\u20133239","journal-title":"Ann Surg Oncol"},{"key":"604_CR77","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/modpathol.2012.228","volume":"26","author":"N Fusco","year":"2013","unstructured":"Fusco N, Rocco EG, Del Conte C et al (2013) HER2 in gastric cancer: a digital image analysis in pre-neoplastic, primary and metastatic lesions. Mod Pathol 26:816\u2013824","journal-title":"Mod Pathol"},{"key":"604_CR78","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/S0360-3016(03)00203-7","volume":"56","author":"X Gao","year":"2003","unstructured":"Gao X, Fisher SG, Emami B (2003) Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Int J Rad Oncol Biol Phys 56:1038\u20131045","journal-title":"Int J Rad Oncol Biol Phys"},{"issue":"15 suppl","key":"604_CR79","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1200\/JCO.2018.36.15_suppl.2547","volume":"36","author":"MS Gordon","year":"2018","unstructured":"Gordon MS, Shapiro G, Sarantopoulos J et al (2018) A phase 1b study of the safety, pharmacokinetics, and preliminary antitumor activity of citarinostat (ACY-241) in combination with paclitaxel (Pac) in patients (pts) with advanced solid tumors (AST). J Clin Oncol 36(15 suppl):2547\u20132547","journal-title":"J Clin Oncol"},{"key":"604_CR80","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.molonc.2014.09.001","volume":"9","author":"KB Greve","year":"2015","unstructured":"Greve KB, Lindgreen JN, Terp MG et al (2015) Ectopic expression of cancer\/testis antigen SSX2 induces DNA damage and promotes genomic instability. Mol Oncol 9:437\u2013449","journal-title":"Mol Oncol"},{"key":"604_CR81","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/scbi.1998.0119","volume":"9","author":"S Hammarstr\u00f6m","year":"1999","unstructured":"Hammarstr\u00f6m S (1999) The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin Cancer Biol 9:67\u201381","journal-title":"Semin Cancer Biol"},{"key":"604_CR82","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/glycob\/10.5.439","volume":"10","author":"FG Hanisch","year":"2000","unstructured":"Hanisch FG, M\u00fcller S (2000) MUC1: the polymorphic appearance of a human mucin. Glycobiology 10:439\u2013449","journal-title":"Glycobiology"},{"key":"604_CR83","first-page":"165","volume":"10","author":"CW Hanke","year":"2011","unstructured":"Hanke CW, Swanson N, Bruce S et al (2011) Complete clearance is sustained for at least 12 months after treatment of actinic keratoses of the face or balding scalp via daily dosing with imiquimod 3.75% or 2.5% cream. J Drugs Dermatol 10:165\u2013170","journal-title":"J Drugs Dermatol"},{"key":"604_CR84","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0030-4220(85)90313-5","volume":"60","author":"LS Hansen","year":"1985","unstructured":"Hansen LS, Olson JA, Silverman S Jr (1985) Proliferative verrucous leukoplakia: a long-term study of thirty patients. Oral Surg Oral Med Oral Pathol 60:285\u2013298","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"604_CR85","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/ni758","volume":"3","author":"H Hemmi","year":"2002","unstructured":"Hemmi H, Kaisho T, Takeuchi O et al (2002) Small anti-viral compounds activate immune cells via the TLR7 MyD88\u2013dependent signaling pathway. Nat Immunol 3:196\u2013200","journal-title":"Nat Immunol"},{"key":"604_CR86","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1002\/cncr.21873","volume":"106","author":"RB Hird","year":"2006","unstructured":"Hird RB, Chang A, Cimmino V et al (2006) Impact of estrogen receptor expression and other clinicopathologic features on tamoxifen use in ductal carcinoma in situ. Cancer 106:2113\u20132118","journal-title":"Cancer"},{"key":"604_CR87","first-page":"53","volume":"8","author":"SB Ho","year":"1996","unstructured":"Ho SB, Ewing SL, Montgomery CK et al (1996) Altered mucin core peptide immunoreactivity in the colon polyp-carcinoma sequence. Oncol Res 8:53\u201361","journal-title":"Oncol Res"},{"key":"604_CR88","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.4049\/jimmunol.1202351","volume":"190","author":"P Hombrink","year":"2013","unstructured":"Hombrink P, Hassan C, Kester MG et al (2013) Discovery of T cell epitopes implementing HLA-peptidomics into a reverse immunology approach. J Immunol 190:3869\u20133877","journal-title":"J Immunol"},{"key":"604_CR89","doi-asserted-by":"crossref","first-page":"234851","DOI":"10.1155\/2015\/234851","volume":"2015","author":"A Ieni","year":"2015","unstructured":"Ieni A, Barresi V, Rigoli L et al (2015) HER2 status in premalignant, early, and advanced neoplastic lesions of the stomach. Dis Markers 2015:234851","journal-title":"Dis Markers"},{"key":"604_CR90","first-page":"703","volume":"76","author":"C Ilantzis","year":"1997","unstructured":"Ilantzis C, Jothy S, Alpert LC et al (1997) Cell-surface levels of human carcinoembryonic antigen are inversely correlated with colonocyte differentiation in colon carcinogenesis. Lab Invest 76:703\u2013716","journal-title":"Lab Invest"},{"key":"604_CR91","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.3389\/fimmu.2018.03000","volume":"9","author":"B Jabbar","year":"2018","unstructured":"Jabbar B, Rafique S, Salo-Ahen OMH et al (2018) Antigenic peptide prediction from E6 and E7 oncoproteins of HPV types 16 and 18 for therapeutic vaccine design using immunoinformatics and MD simulation analysis. Front Immunol 9:3000","journal-title":"Front Immunol"},{"key":"604_CR92","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/nm.2161","volume":"16","author":"R Jaini","year":"2010","unstructured":"Jaini R, Kesaraju P, Johnson JM et al (2010) An autoimmune-mediated strategy for prophylactic breast cancer vaccination. Nat Med 16:799\u2013803","journal-title":"Nat Med"},{"key":"604_CR93","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4132\/KoreanJPathol.2013.47.5.443","volume":"47","author":"TJ Jang","year":"2013","unstructured":"Jang TJ (2013) Progressive increase of regulatory T cells and decrease of CD8+ T cells and CD8+ T cells\/regulatory T cells ratio during colorectal cancer development. Korean J Pathol 47:443\u2013451","journal-title":"Korean J Pathol"},{"key":"604_CR94","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/nature01441","volume":"421","author":"EM Janssen","year":"2003","unstructured":"Janssen EM, Lemmens EE, Wolfe T et al (2003) CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature 421:852\u2013856","journal-title":"Nature"},{"issue":"3","key":"604_CR95","doi-asserted-by":"publisher","first-page":"147","DOI":"10.18502\/acta.v57i3.1815","volume":"57","author":"S Javan","year":"2019","unstructured":"Javan S, Andalib A, Bereshneh AH et al (2019) Frequent novel variations within MSH2 and MLH1 genes in a subset of iranian families with hereditary non-polyposis colorectal cancer. Acta Medica Iranica 57(3):147\u2013151. https:\/\/doi.org\/10.18502\/acta.v57i3.1815","journal-title":"Acta Medica Iranica"},{"key":"604_CR96","first-page":"2195","volume":"9","author":"M Jeanmart","year":"2003","unstructured":"Jeanmart M, Lantuejoul S, Fievet F et al (2003) Value of immunohistochemical markers in preinvasive bronchial lesions in risk assessment of lung cancer. Clin Cancer Res 9:2195\u20132203","journal-title":"Clin Cancer Res"},{"key":"604_CR97","doi-asserted-by":"crossref","first-page":"e506","DOI":"10.1038\/bcj.2016.114","volume":"6","author":"JR Jones","year":"2016","unstructured":"Jones JR, Cairns DA, Gregory WM et al (2016) Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the myeloma XI trial. Blood Cancer J 6:e506\u2013e506","journal-title":"Blood Cancer J"},{"key":"604_CR98","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.1016\/j.vaccine.2016.09.062","volume":"34","author":"S Jorritsma","year":"2016","unstructured":"Jorritsma S, Gowans E, Grubor-Bauk B et al (2016) Delivery methods to increase cellular uptake and immunogenicity of DNA vaccines. Vaccine 34:5488\u20135494","journal-title":"Vaccine"},{"key":"604_CR99","first-page":"250","volume":"143","author":"S Jothy","year":"1993","unstructured":"Jothy S, Yuan SY, Shirota K (1993) Transcription of carcinoembryonic antigen in normal colon and colon carcinoma. In situ hybridization study and implication for a new in vivo functional model. Am J Pathol 143:250\u2013257","journal-title":"Am J Pathol"},{"key":"604_CR100","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1182\/blood-2004-12-4931","volume":"106","author":"AA Jungbluth","year":"2005","unstructured":"Jungbluth AA, Ely S, DiLiberto M et al (2005) The cancer-testis antigens CT7 (MAGE-C1) and MAGE-A3\/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation. Blood 106:167\u2013174","journal-title":"Blood"},{"key":"604_CR101","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1001294","volume":"363","author":"PW Kantoff","year":"2010","unstructured":"Kantoff PW, Higano CS, Shore ND et al (2010) Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med 363:411\u2013422","journal-title":"N Engl J Med"},{"key":"604_CR102","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.bpg.2015.09.011","volume":"29","author":"JH Kao","year":"2015","unstructured":"Kao JH (2015) Hepatitis B vaccination and prevention of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol 29:907\u2013917","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"604_CR103","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/10520299609117128","volume":"71","author":"FH Kasten","year":"1996","unstructured":"Kasten FH (1996) Paul Ehrlich: pathfinder in cell biology. 1. Chronicle of his life and accomplishments in immunology, cancer research, and chemotherapy. Biotech Histochem 71:2\u201337","journal-title":"Biotech Histochem"},{"key":"604_CR104","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1158\/1940-6207.CAPR-15-0406","volume":"9","author":"TW Kensler","year":"2016","unstructured":"Kensler TW, Spira AJE, Garber JE et al (2016) Transforming cancer prevention through precision medicine and immune-oncology. Cancer Prev Res 9:2\u201310","journal-title":"Cancer Prev Res"},{"key":"604_CR105","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa0810097","volume":"361","author":"GG Kenter","year":"2009","unstructured":"Kenter GG, Welters MJ, Valentijn AR et al (2009) Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia. N Engl J Med 361:1838\u20131847","journal-title":"N Engl J Med"},{"key":"604_CR106","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12664-015-0534-y","volume":"34","author":"MV Kesari","year":"2015","unstructured":"Kesari MV, Gaopande VL, Joshi AR et al (2015) Immunohistochemical study of MUC1, MUC2 and MUC5AC in colorectal carcinoma and review of literature. Indian J Gastroenterol 34:63\u201367","journal-title":"Indian J Gastroenterol"},{"key":"604_CR107","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/sj.leu.2404787","volume":"21","author":"JH Kessler","year":"2007","unstructured":"Kessler JH, Melief CJM (2007) Identification of T-cell epitopes for cancer immunotherapy. Leukemia 21:1859\u20131874","journal-title":"Leukemia"},{"key":"604_CR108","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/ni1102-999","volume":"3","author":"HT Khong","year":"2002","unstructured":"Khong HT, Restifo NP (2002) Natural selection of tumor variants in the generation of \u201ctumor escape\u201d phenotypes. Nat Immunol 3:999\u20131005","journal-title":"Nat Immunol"},{"key":"604_CR109","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/00002371-200405000-00002","volume":"27","author":"HT Khong","year":"2004","unstructured":"Khong HT, Wang QJ, Rosenberg SA (2004) Identification of multiple antigens recognized by tumor-infiltrating lymphocytes from a single patient: tumor escape by antigen loss and loss of MHC expression. J Immunother 27:184","journal-title":"J Immunother"},{"key":"604_CR110","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3949\/ccjm.86a.17133","volume":"86","author":"J Khouri","year":"2019","unstructured":"Khouri J, Samaras C, Valent J et al (2019) Monoclonal gammopathy of undetermined significance: a primary care guide. Cleve Clin J Med 86:39\u201346","journal-title":"Cleve Clin J Med"},{"key":"604_CR111","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1158\/1940-6207.CAPR-12-0275","volume":"6","author":"T Kimura","year":"2013","unstructured":"Kimura T, McKolanis JR, Dzubinski LA et al (2013) MUC1 vaccine for individuals with advanced adenoma of the colon: a cancer immunoprevention feasibility study. Cancer Prev Res 6:18\u201326","journal-title":"Cancer Prev Res"},{"key":"604_CR112","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/imcb.12280","volume":"97","author":"JR Kirman","year":"2019","unstructured":"Kirman JR, Quinn KM, Seder RA (2019) Immunological memory. Immunol Cell Biol 97:615\u2013616","journal-title":"Immunol Cell Biol"},{"key":"604_CR113","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/nature06309","volume":"450","author":"CM Koebel","year":"2007","unstructured":"Koebel CM, Vermi W, Swann JB et al (2007) Adaptive immunity maintains occult cancer in an equilibrium state. Nature 450:903\u2013907","journal-title":"Nature"},{"key":"604_CR114","doi-asserted-by":"crossref","first-page":"135916","DOI":"10.1155\/2014\/135916","volume":"2014","author":"D Kopera","year":"2014","unstructured":"Kopera D, Kerl H (2014) Visualization and treatment of subclinical actinic keratoses with topical imiquimod 5%; cream: an observational study. Biomed Res Int 2014:135916","journal-title":"Biomed Res Int"},{"key":"604_CR115","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/CJI.0b013e318235f512","volume":"35","author":"GK Koski","year":"2012","unstructured":"Koski GK, Koldovsky U, Xu S et al (2012) A novel dendritic cell-based immunization approach for the induction of durable Th1-polarized anti-HER-2\/neu responses in women with early breast cancer. J Immunother 35:54\u201365","journal-title":"J Immunother"},{"key":"604_CR116","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1756-8722-2-36","volume":"2","author":"V Kotla","year":"2009","unstructured":"Kotla V, Goel S, Nischal S et al (2009) Mechanism of action of lenalidomide in hematological malignancies. J Hematol Oncol 2:36","journal-title":"J Hematol Oncol"},{"key":"604_CR117","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.clim.2015.10.001","volume":"177","author":"Y Krasnova","year":"2017","unstructured":"Krasnova Y, Putz EM, Smyth MJ et al (2017) Bench to bedside: NK cells and control of metastasis. Clin Immunol 177:50\u201359","journal-title":"Clin Immunol"},{"key":"604_CR118","first-page":"17","volume":"31","author":"RS Krouse","year":"2009","unstructured":"Krouse RS, Alberts DS, Prasad AR et al (2009) Progression of skin lesions from normal skin to squamous cell carcinoma. Anal Quant Cytol Histol 31:17\u201325","journal-title":"Anal Quant Cytol Histol"},{"key":"604_CR119","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1056\/NEJMoa070389","volume":"356","author":"RA Kyle","year":"2007","unstructured":"Kyle RA, Remstein ED, Therneau TM et al (2007) Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma. N Engl J Med 356:2582\u20132590","journal-title":"N Engl J Med"},{"key":"604_CR120","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1159\/000337003","volume":"30","author":"L Laghi","year":"2012","unstructured":"Laghi L, Malesci A (2012) Microsatellite instability and therapeutic consequences in colorectal cancer. Dig Dis 30:304\u2013309","journal-title":"Dig Dis"},{"key":"604_CR121","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","volume":"113","author":"O Landgren","year":"2009","unstructured":"Landgren O, Kyle RA, Pfeiffer RM et al (2009) Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood 113:5412\u20135417","journal-title":"Blood"},{"key":"604_CR122","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3390\/diagnostics10070503","volume":"10","author":"D Laville","year":"2020","unstructured":"Laville D, Casteillo F, Yvorel V et al (2020) Immune escape is an early event in pre-invasive lesions of lung squamous cell carcinoma. Diagnostics 10:503","journal-title":"Diagnostics"},{"key":"604_CR123","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","volume":"383","author":"J Lei","year":"2020","unstructured":"Lei J, Ploner A, Elfstr\u00f6m KM et al (2020) HPV vaccination and the risk of invasive cervical cancer. N Engl J Med 383:1340\u20131348","journal-title":"N Engl J Med"},{"key":"604_CR124","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/annonc\/mdl072","volume":"17","author":"WJ Lesterhuis","year":"2006","unstructured":"Lesterhuis WJ, de Vries IJM, Schuurhuis DH et al (2006) Vaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin tests. Ann Oncol 17:974\u2013980","journal-title":"Ann Oncol"},{"key":"604_CR125","first-page":"5091","volume":"30","author":"WJ Lesterhuis","year":"2010","unstructured":"Lesterhuis WJ, de Vries IJM, Schreibelt G et al (2010) Immunogenicity of dendritic cells pulsed with CEA peptide or transfected with CEA mRNA for vaccination of colorectal cancer patients. Anticancer Res 30:5091\u20135097","journal-title":"Anticancer Res"},{"key":"604_CR126","first-page":"29","volume":"2","author":"SH Lim","year":"2012","unstructured":"Lim SH, Zhang Y, Zhang J (2012) Cancer-testis antigens: the current status on antigen regulation and potential clinical use. Am J Blood Res 2:29\u201335","journal-title":"Am J Blood Res"},{"key":"604_CR127","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.2174\/138945011798184146","volume":"12","author":"PL Lollini","year":"2011","unstructured":"Lollini PL, Nicoletti G, Landuzzi L et al (2011) Vaccines and other immunological approaches for cancer immunoprevention. Curr Drug Targets 12:1957\u20131973","journal-title":"Curr Drug Targets"},{"key":"604_CR128","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41698-018-0075-9","volume":"3","author":"HA Loomans-Kropp","year":"2019","unstructured":"Loomans-Kropp HA, Umar A (2019) Cancer prevention and screening: the next step in the era of precision medicine. NPJ Prec Oncol 3:3","journal-title":"NPJ Prec Oncol"},{"key":"604_CR129","volume-title":"Patient safety and quality: an evidence-based handbook for nurses","author":"C Loveland-Cherry","year":"2008","unstructured":"Loveland-Cherry C (2008) Section III: patient\u2014centered care 16. Prevention\u2014safety and quality. In: Hughes RG (ed) Patient safety and quality: an evidence-based handbook for nurses. Agency for Healthcare Research and Quality U.S Department of Health and Human Services, Rockville"},{"key":"604_CR130","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1476-4598-13-78","volume":"13","author":"FJ Lowe","year":"2014","unstructured":"Lowe FJ, Shen W, Zu J et al (2014) A novel autoantibody test for the detection of pre-neoplastic lung lesions. Mol Cancer 13:78","journal-title":"Mol Cancer"},{"key":"604_CR131","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1158\/1078-0432.CCR-16-1924","volume":"23","author":"L Lowenfeld","year":"2017","unstructured":"Lowenfeld L, Mick R, Datta J et al (2017) Dendritic cell vaccination enhances immune responses and induces regression of HER2(pos) DCIS independent of route: results of randomized selection design trial. Clin Cancer Res 23:2961\u20132971","journal-title":"Clin Cancer Res"},{"key":"604_CR132","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1158\/1940-6207.CAPR-11-0542","volume":"5","author":"DR Lowy","year":"2012","unstructured":"Lowy DR, Schiller JT (2012) Reducing HPV-associated cancer globally. Cancer Prev Res 5:18\u201323","journal-title":"Cancer Prev Res"},{"key":"604_CR133","doi-asserted-by":"crossref","unstructured":"Ma P, Beatty P, McKolanis J et al (2018) Myeloid derived suppressor cells (MDSC) and anti-MUC1 immunosurveillance in pre-malignancy and cancer. 200(1 Supplement):122.117","DOI":"10.4049\/jimmunol.200.Supp.122.17"},{"key":"604_CR134","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.4049\/jimmunol.154.10.5071","volume":"154","author":"SE Macatonia","year":"1995","unstructured":"Macatonia SE, Hosken NA, Litton M et al (1995) Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol 154:5071\u20135079","journal-title":"J Immunol"},{"key":"604_CR135","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.annonc.2019.10.008","volume":"31","author":"DE Magee","year":"2020","unstructured":"Magee DE, Hird AE, Klaassen Z et al (2020) Adverse event profile for immunotherapy agents compared with chemotherapy in solid organ tumors: a systematic review and meta-analysis of randomized clinical trials. Ann Oncol 31:50\u201360","journal-title":"Ann Oncol"},{"key":"604_CR136","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/sj.bjc.6602022","volume":"91","author":"J Maher","year":"2004","unstructured":"Maher J, Davies ET (2004) Targeting cytotoxic T lymphocytes for cancer immunotherapy. Br J Cancer 91:817\u2013821","journal-title":"Br J Cancer"},{"key":"604_CR137","doi-asserted-by":"crossref","first-page":"5934","DOI":"10.1158\/0008-5472.CAN-04-1261","volume":"64","author":"RB Mailliard","year":"2004","unstructured":"Mailliard RB, Wankowicz-KalinskaCai AQQ et al (2004) Alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity. Cancer Res 64:5934\u20135937","journal-title":"Cancer Res"},{"key":"604_CR138","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1097\/01.MP.0000086072.56290.FB","volume":"16","author":"A Maitra","year":"2003","unstructured":"Maitra A, Adsay NV, Argani P et al (2003) Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray. Mod Pathol 16:902\u2013912","journal-title":"Mod Pathol"},{"key":"604_CR139","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2741\/2692","volume":"13","author":"FO Martinez","year":"2008","unstructured":"Martinez FO, Sica A, Mantovani A et al (2008) Macrophage activation and polarization. Front Biosci 13:453\u2013461","journal-title":"Front Biosci"},{"key":"604_CR140","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41571-019-0218-0","volume":"16","author":"F Martins","year":"2019","unstructured":"Martins F, Sofiya L, Sykiotis GP et al (2019) Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance. Nat Rev Clin Oncol 16:563\u2013580","journal-title":"Nat Rev Clin Oncol"},{"key":"604_CR141","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s41586-019-1330-0","volume":"571","author":"C Mascaux","year":"2019","unstructured":"Mascaux C, Angelova M, Vasaturo A et al (2019) Immune evasion before tumour invasion in early lung squamous carcinogenesis. Nature 571:570\u2013575","journal-title":"Nature"},{"key":"604_CR142","doi-asserted-by":"crossref","first-page":"e5611","DOI":"10.1371\/journal.pone.0005611","volume":"4","author":"PP Massion","year":"2009","unstructured":"Massion PP, Zou Y, Uner H et al (2009) Recurrent genomic gains in preinvasive lesions as a biomarker of risk for lung cancer. PLoS ONE 4:e5611","journal-title":"PLoS ONE"},{"key":"604_CR143","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1056\/NEJMoa1300439","volume":"369","author":"MV Mateos","year":"2013","unstructured":"Mateos MV, Hern\u00e1ndez MT, Giraldo P et al (2013) Lenalidomide plus dexamethasone for high-risk smoldering multiple myeloma. N Engl J Med 369:438\u2013447","journal-title":"N Engl J Med"},{"key":"604_CR144","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1158\/1940-6207.CAPR-17-0154","volume":"10","author":"S Mazumder","year":"2017","unstructured":"Mazumder S, Johnson JM, Swank V et al (2017) Primary immunoprevention of epithelial ovarian carcinoma by vaccination against the extracellular domain of anti-m\u00fcllerian hormone receptor II. Cancer Prev Res 10:612\u2013624","journal-title":"Cancer Prev Res"},{"key":"604_CR145","first-page":"154","volume":"26","author":"EF McCarthy","year":"2006","unstructured":"McCarthy EF (2006) The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas. Iowa Orthop J 26:154\u2013158","journal-title":"Iowa Orthop J"},{"key":"604_CR146","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/cld.753","volume":"12","author":"M McConnell","year":"2018","unstructured":"McConnell M, Lim JK (2018) Hepatitis C vaccine development in the era of direct-acting antivirals. Clin Liver Dis 12:118\u2013121","journal-title":"Clin Liver Dis"},{"key":"604_CR147","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpg.2004.10.004","volume":"19","author":"KA McGlynn","year":"2005","unstructured":"McGlynn KA, London WT (2005) Epidemiology and natural history of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol 19:3\u201323","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"604_CR148","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/0046-8177(95)90146-9","volume":"26","author":"MA McGuckin","year":"1995","unstructured":"McGuckin MA, Walsh MD, Hohn BG et al (1995) Prognostic significance of muc1 epithelial mucin expression in breast cancer. Hum Pathol 26:432\u2013439","journal-title":"Hum Pathol"},{"key":"604_CR149","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0192-0561(98)00068-X","volume":"21","author":"R Miller","year":"1999","unstructured":"Miller R, Gerster J, Owens M et al (1999) Review article imiquimod applied topically: a novel immune response modifier and new class of drug. Int J Immunopharmacol 21:1\u201314","journal-title":"Int J Immunopharmacol"},{"key":"604_CR150","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1186\/1471-2407-10-537","volume":"10","author":"M Molaei","year":"2010","unstructured":"Molaei M, Mansoori BK, Mashayekhi R et al (2010) Mucins in neoplastic spectrum of colorectal polyps: can they provide predictions? BMC Cancer 10:537\u2013537","journal-title":"BMC Cancer"},{"key":"604_CR151","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF00632180","volume":"3","author":"A Morales","year":"1986","unstructured":"Morales A, Nickel JC (1986) Immunotherapy of superficial bladder cancer with BCG. World J Urol 3:209\u2013214","journal-title":"World J Urol"},{"key":"604_CR152","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.vaccine.2006.11.007","volume":"25","author":"P Mukherjee","year":"2007","unstructured":"Mukherjee P, Pathangey LB, Bradley JB et al (2007) MUC1-specific immune therapy generates a strong anti-tumor response in a MUC1-tolerant colon cancer model. Vaccine 25:1607\u20131618","journal-title":"Vaccine"},{"key":"604_CR153","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1600-065X.1990.tb00803.x","volume":"116","author":"B Mukherji","year":"1990","unstructured":"Mukherji B, Chakraborty NG, Sivanandham M (1990) T-cell clones that react against autologous human tumors. Immunol Rev 116:33\u201362","journal-title":"Immunol Rev"},{"key":"604_CR154","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nri.2017.49","volume":"17","author":"N Nagarsheth","year":"2017","unstructured":"Nagarsheth N, Wicha MS, Zou W (2017) Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nat Rev Immunol 17:559\u2013572","journal-title":"Nat Rev Immunol"},{"key":"604_CR155","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1084\/jem.194.9.1195","volume":"194","author":"P Nanni","year":"2001","unstructured":"Nanni P, Nicoletti G, De Giovanni C et al (2001) Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2\/neu transgenic mice. J Exp Med 194:1195\u20131205","journal-title":"J Exp Med"},{"key":"604_CR156","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1158\/1078-0432.CCR-10-1820","volume":"17","author":"T Nardiello","year":"2011","unstructured":"Nardiello T, Jungbluth AA, Mei A et al (2011) MAGE-A inhibits apoptosis in proliferating myeloma cells through repression of Bax and maintenance of survivin. Clin Cancer Res 17:4309\u20134319","journal-title":"Clin Cancer Res"},{"key":"604_CR157","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ijc.25429","volume":"127","author":"H Nishikawa","year":"2010","unstructured":"Nishikawa H, Sakaguchi S (2010) Regulatory T cells in tumor immunity. Int J Cancer 127:759\u2013767","journal-title":"Int J Cancer"},{"key":"604_CR158","doi-asserted-by":"crossref","first-page":"e183267","DOI":"10.1001\/jamaoncol.2018.3267","volume":"4","author":"AK Nooka","year":"2018","unstructured":"Nooka AK, Wang ML, Yee AJ et al (2018) Assessment of safety and immunogenicity of PVX-410 Vaccine with or without lenalidomide in patients with smoldering multiple myeloma: a nonrandomized clinical trial. JAMA Oncol 4:e183267","journal-title":"JAMA Oncol"},{"key":"604_CR159","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1084\/jem.187.5.693","volume":"187","author":"F Ossendorp","year":"1998","unstructured":"Ossendorp F, Mengede E, Camps M et al (1998) Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors. J Exp Med 187:693\u2013702","journal-title":"J Exp Med"},{"key":"604_CR160","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1464-410X.2004.04922.x","volume":"94","author":"HS Pandha","year":"2004","unstructured":"Pandha HS, John RJ, Hutchinson J et al (2004) Dendritic cell immunotherapy for urological cancers using cryopreserved allogeneic tumour lysate-pulsed cells: a phase I\/II study. BJU Int 94:412\u2013418","journal-title":"BJU Int"},{"key":"604_CR161","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1365-2559.2006.02403.x","volume":"48","author":"K Park","year":"2006","unstructured":"Park K, Han S, Kim H et al (2006) HER2 status in pure ductal carcinoma in situ and in the intraductal and invasive components of invasive ductal carcinoma determined by fluorescence in situ hybridization and immunohistochemistry. Histopathology 48:702\u2013707","journal-title":"Histopathology"},{"key":"604_CR162","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/jnci\/83.9.640","volume":"83","author":"J Parsonnet","year":"1991","unstructured":"Parsonnet J, Vandersteen D, Goates J et al (1991) Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas. J Natl Cancer Inst 83:640\u2013643","journal-title":"J Natl Cancer Inst"},{"key":"604_CR163","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1158\/2159-8290.CD-19-1366","volume":"10","author":"A Pennycuick","year":"2020","unstructured":"Pennycuick A, Teixeira VH, AbdulJabbar K et al (2020) Immune surveillance in clinical regression of preinvasive squamous cell lung cancer. Cancer Discov 10:1489\u20131499","journal-title":"Cancer Discov"},{"key":"604_CR164","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ijc.31664","volume":"144","author":"S Pilleron","year":"2019","unstructured":"Pilleron S, Sarfati D, Janssen-Heijnen M et al (2019) Global cancer incidence in older adults, 2012 and 2035: a population-based study. Int J Cancer 144:49\u201358","journal-title":"Int J Cancer"},{"key":"604_CR165","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.prp.2013.08.004","volume":"209","author":"KC Piotti","year":"2013","unstructured":"Piotti KC, Scognamiglio T, Chiu T et al (2013) Expression of cancer\/testis (CT) antigens in squamous cell carcinoma of the head and neck: evaluation as markers of squamous dysplasia. Pathol Res Pract 209:721\u2013726","journal-title":"Pathol Res Pract"},{"key":"604_CR166","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S1470-2045(20)30074-7","volume":"21","author":"MJ Pishvaian","year":"2020","unstructured":"Pishvaian MJ, Blais EM, Brody JR et al (2020) Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial. Lancet Oncol 21:508\u2013518","journal-title":"Lancet Oncol"},{"key":"604_CR167","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1182\/blood-2010-12-325035","volume":"118","author":"J Popovi\u0107","year":"2011","unstructured":"Popovi\u0107 J, Li LP, Kloetzel PM et al (2011) The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed. Blood 118:946\u2013954","journal-title":"Blood"},{"key":"604_CR168","doi-asserted-by":"crossref","first-page":"14475","DOI":"10.1074\/jbc.M109.084400","volume":"285","author":"E Por","year":"2010","unstructured":"Por E, Byun HJ, Lee EJ et al (2010) The cancer\/testis antigen CAGE with oncogenic potential stimulates cell proliferation by up-regulating cyclins D1 and E in an AP-1-and E2F-dependent manner. J Biol Chem 285:14475\u201314485","journal-title":"J Biol Chem"},{"key":"604_CR169","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/sj.gt.3301360","volume":"8","author":"SM Pupa","year":"2001","unstructured":"Pupa SM, Invernizzi AM, Forti S et al (2001) Prevention of spontaneous neu-expressing mammary tumor development in mice transgenic for rat proto-neu by DNA vaccination. Gene Ther 8:75\u201379","journal-title":"Gene Ther"},{"key":"604_CR170","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1038\/sj.bjc.6602232","volume":"91","author":"CF Qu","year":"2004","unstructured":"Qu CF, Li Y, Song YJ et al (2004) MUC1 expression in primary and metastatic pancreatic cancer cells for in vitro treatment by (213)Bi-C595 radioimmunoconjugate. Br J Cancer 91:2086\u20132093","journal-title":"Br J Cancer"},{"key":"604_CR171","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1517\/14656566.2011.549128","volume":"12","author":"SR Quist","year":"2011","unstructured":"Quist SR, Gollnick HP (2011) Imiquimod 3.75% cream (Zyclara) for the treatment of actinic keratoses. Expert Opin Pharmacother 12:451\u2013461","journal-title":"Expert Opin Pharmacother"},{"key":"604_CR172","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1002\/ijc.28622","volume":"134","author":"PL Raber","year":"2014","unstructured":"Raber PL, Thevenot P, Sierra R et al (2014) Subpopulations of myeloid-derived suppressor cells impair T cell responses through independent nitric oxide-related pathways. Int J Cancer 134:2853\u20132864","journal-title":"Int J Cancer"},{"key":"604_CR173","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/modpathol.3800445","volume":"18","author":"EA Rakha","year":"2005","unstructured":"Rakha EA, Boyce RWG, Abd El-Rehim D et al (2005) Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer. Mod Pathol 18:1295\u20131304","journal-title":"Mod Pathol"},{"key":"604_CR174","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12105-012-0367-2","volume":"6","author":"J Rautava","year":"2012","unstructured":"Rautava J, Syrj\u00e4nen S (2012) Biology of human papillomavirus infections in head and neck carcinogenesis. Head Neck Pathol 6:3\u201315","journal-title":"Head Neck Pathol"},{"issue":"Suppl 2","key":"604_CR175","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1464-410X.2007.06947.x","volume":"100","author":"V Ravery","year":"2007","unstructured":"Ravery V (2007) Chemotherapy of premalignant lesions: new insights. BJU Int 100(Suppl 2):18\u201321","journal-title":"BJU Int"},{"key":"604_CR176","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12967-017-1250-4","volume":"15","author":"V Rolih","year":"2017","unstructured":"Rolih V, Barutello G, Iussich S et al (2017) CSPG4: a prototype oncoantigen for translational immunotherapy studies. J Transl Med 15:151","journal-title":"J Transl Med"},{"key":"604_CR177","first-page":"77","volume":"5","author":"U Romeo","year":"2014","unstructured":"Romeo U, Russo N, Palaia G et al (2014) Oral proliferative verrucous leukoplakia treated with the photodynamic therapy: a case report. Ann Stomatol 5:77\u201380","journal-title":"Ann Stomatol"},{"key":"604_CR178","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1365-2133.2012.11061.x","volume":"167","author":"MH Roozeboom","year":"2012","unstructured":"Roozeboom MH, Arits AH, Nelemans PJ et al (2012) Overall treatment success after treatment of primary superficial basal cell carcinoma: a systematic review and meta-analysis of randomized and nonrandomized trials. Br J Dermatol 167:733\u2013756","journal-title":"Br J Dermatol"},{"key":"604_CR179","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1111\/j.1582-4934.2008.00517.x","volume":"13","author":"E Rossi","year":"2009","unstructured":"Rossi E, Grisanti S, Villanacci V et al (2009) HER-2 overexpression\/amplification in Barrett\u2019s oesophagus predicts early transition from dysplasia to adenocarcinoma: a clinico-pathologic study. J Cell Mol Med 13:3826\u20133833","journal-title":"J Cell Mol Med"},{"key":"604_CR180","doi-asserted-by":"crossref","first-page":"13255","DOI":"10.1073\/pnas.231326898","volume":"98","author":"I Saeterdal","year":"2001","unstructured":"Saeterdal I, Bjorheim J, Lislerud K et al (2001) Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer. Proc Natl Acad Sci USA 98:13255\u201313260","journal-title":"Proc Natl Acad Sci USA"},{"key":"604_CR181","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.cdp.2005.04.003","volume":"29","author":"U Schiemann","year":"2005","unstructured":"Schiemann U, G\u00fcnther S, Gross M et al (2005) Preoperative serum levels of the carcinoembryonic antigen in hereditary non-polyposis colorectal cancer compared to levels in sporadic colorectal cancer. Cancer Detect Prev 29:356\u2013360","journal-title":"Cancer Detect Prev"},{"issue":"Suppl 5","key":"604_CR182","doi-asserted-by":"crossref","first-page":"F123","DOI":"10.1016\/j.vaccine.2012.04.108","volume":"30","author":"JT Schiller","year":"2012","unstructured":"Schiller JT, Castellsague X, Garland SM (2012) A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine 30(Suppl 5):F123-138","journal-title":"Vaccine"},{"key":"604_CR183","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.4049\/jimmunol.1201018","volume":"189","author":"E Schlecker","year":"2012","unstructured":"Schlecker E, Stojanovic A, Eisen C et al (2012) Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth. J Immunol 189:5602\u20135611","journal-title":"J Immunol"},{"key":"604_CR184","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/31002","volume":"393","author":"SP Schoenberger","year":"1998","unstructured":"Schoenberger SP, Toes RE, van der Voort EI et al (1998) T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480\u2013483","journal-title":"Nature"},{"key":"604_CR185","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","volume":"331","author":"RD Schreiber","year":"2011","unstructured":"Schreiber RD, Old LJ, Smyth MJ (2011) Cancer immunoediting: Integrating immunity\u2019s roles in cancer suppression and promotion. Science 331:1565\u20131570","journal-title":"Science"},{"key":"604_CR186","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0092-8674(05)80055-8","volume":"71","author":"RH Schwartz","year":"1992","unstructured":"Schwartz RH (1992) Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7\/BB1 in interleukin-2 production and immunotherapy. Cell 71:1065\u20131068","journal-title":"Cell"},{"key":"604_CR187","doi-asserted-by":"crossref","first-page":"e21443","DOI":"10.1371\/journal.pone.0021443","volume":"6","author":"SA Selamat","year":"2011","unstructured":"Selamat SA, Galler JS, Joshi AD et al (2011) DNA methylation changes in atypical adenomatous hyperplasia, adenocarcinoma in situ, and lung adenocarcinoma. PLoS ONE 6:e21443","journal-title":"PLoS ONE"},{"key":"604_CR188","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1158\/0008-5472.CAN-07-6621","volume":"68","author":"P Serafini","year":"2008","unstructured":"Serafini P, Mgebroff S, Noonan K et al (2008) Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells. Cancer Res 68:5439\u20135449","journal-title":"Cancer Res"},{"key":"604_CR189","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.ejca.2015.06.001","volume":"51","author":"B Serrano","year":"2015","unstructured":"Serrano B, de Sanjos\u00e9 S, Tous S et al (2015) Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions. Eur J Cancer 51:1732\u20131741","journal-title":"Eur J Cancer"},{"key":"604_CR190","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1002\/cncr.26734","volume":"118","author":"A Sharma","year":"2012","unstructured":"Sharma A, Koldovsky U, Xu S et al (2012) HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact ductal carcinoma in situ. Cancer 118:4354\u20134362","journal-title":"Cancer"},{"key":"604_CR191","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nri727","volume":"2","author":"AH Sharpe","year":"2002","unstructured":"Sharpe AH, Freeman GJ (2002) The B7\u2013CD28 superfamily. Nat Rev Immunol 2:116\u2013126","journal-title":"Nat Rev Immunol"},{"key":"604_CR192","doi-asserted-by":"crossref","first-page":"278","DOI":"10.4049\/jimmunol.1700339","volume":"199","author":"JH Sheen","year":"2017","unstructured":"Sheen JH, Strainic MG, Liu J et al (2017) TLR-induced murine dendritic cell (DC) activation requires DC-intrinsic complement. J Immunol 199:278\u2013291","journal-title":"J Immunol"},{"key":"604_CR193","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/00000658-197912000-00001","volume":"190","author":"H Shinya","year":"1979","unstructured":"Shinya H, Wolff WI (1979) Morphology, anatomic distribution and cancer potential of colonic polyps. Ann Surg 190:679\u2013683","journal-title":"Ann Surg"},{"key":"604_CR194","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1158\/1940-6207.CAPR-17-0188","volume":"10","author":"RH Shoemaker","year":"2017","unstructured":"Shoemaker RH, Forsthuber TG (2017) Targeting \u201cRetired antigens\u201d for cancer immunoprevention. Cancer Prev Res 10:607\u2013608","journal-title":"Cancer Prev Res"},{"key":"604_CR195","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S1079-2104(97)90062-7","volume":"84","author":"S Silverman Jr","year":"1997","unstructured":"Silverman S Jr, Gorsky M (1997) Proliferative verrucous leukoplakia: a follow-up study of 54 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 84:154\u2013157","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"604_CR196","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/jso.20708","volume":"95","author":"MJ Silverstein","year":"2007","unstructured":"Silverstein MJ, Lagios MD (2007) Should all patients undergoing breast conserving therapy for DCIS receive radiation therapy? No. One size does not fit all: an argument against the routine use of radiation therapy for all patients with ductal carcinoma in situ of the breast who elect breast conservation. J Surg Oncol 95:605\u2013609","journal-title":"J Surg Oncol"},{"key":"604_CR197","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1039\/C5SC03892H","volume":"7","author":"M Skwarczynski","year":"2016","unstructured":"Skwarczynski M, Toth I (2016) Peptide-based synthetic vaccines. Chem Sci 7:842\u2013854","journal-title":"Chem Sci"},{"key":"604_CR198","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","volume":"235","author":"DJ Slamon","year":"1987","unstructured":"Slamon DJ, Clark GM, Wong SG et al (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2\/neu oncogene. Science 235:177\u2013182","journal-title":"Science"},{"key":"604_CR199","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1200\/JCO.2015.60.8588","volume":"33","author":"LJ Solin","year":"2015","unstructured":"Solin LJ, Gray R, Hughes LL et al (2015) Surgical excision without radiation for ductal carcinoma in situ of the breast: 12-year results from the ECOG-ACRIN E5194 study. J Clin Oncol 33:3938\u20133944","journal-title":"J Clin Oncol"},{"key":"604_CR200","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1158\/0008-5472.CAN-05-2823","volume":"66","author":"C Spangenberg","year":"2006","unstructured":"Spangenberg C, Lausch EU, Trost TM et al (2006) ERBB2-mediated transcriptional up-regulation of the \u03b15\u03b21 integrin fibronectin receptor promotes tumor cell survival under adverse conditions. Cancer Res 66:3715\u20133725","journal-title":"Cancer Res"},{"key":"604_CR201","first-page":"2127","volume":"63","author":"Z Su","year":"2003","unstructured":"Su Z, Dannull J, Heiser A et al (2003) Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells. Cancer Res 63:2127\u20132133","journal-title":"Cancer Res"},{"key":"604_CR202","first-page":"166","volume":"13","author":"N Swanson","year":"2014","unstructured":"Swanson N, Smith CC, Kaur M et al (2014) Imiquimod 2.5 and 3.75% for the treatment of actinic keratoses: two phase 3, multicenter, randomized, double-blind, placebo-controlled studies. J Drugs Dermatol 13:166\u2013169","journal-title":"J Drugs Dermatol"},{"key":"604_CR203","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/01.cji.0000175685.36239.e5","volume":"28","author":"BJ Taylor","year":"2005","unstructured":"Taylor BJ, Reiman T, Pittman JA et al (2005) SSX cancer testis antigens are expressed in most multiple myeloma patients: co-expression of SSX1, 2, 4, and 5 correlates with adverse prognosis and high frequencies of SSX-positive PCs. J Immunother 28:564\u2013575","journal-title":"J Immunother"},{"key":"604_CR204","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.3389\/fimmu.2018.01838","volume":"9","author":"M Terabe","year":"2018","unstructured":"Terabe M, Berzofsky JA (2018) Tissue-specific roles of NKT cells in tumor immunity. Front Immunol 9:1838\u20131838","journal-title":"Front Immunol"},{"key":"604_CR205","first-page":"529","volume-title":"Cellular and humoral aspects of the hypersensitive states","author":"L Thomas","year":"1959","unstructured":"Thomas L (1959) Discussion. In: Lawrence HS (ed) Cellular and humoral aspects of the hypersensitive states. Hoeber-Harper, New York, pp 529\u2013532"},{"key":"604_CR206","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.1038\/sj.onc.1205847","volume":"21","author":"JF Timms","year":"2002","unstructured":"Timms JF, White SL, O\u2019Hare MJ et al (2002) Effects of ErbB-2 overexpression on mitogenic signalling and cell cycle progression in human breast luminal epithelial cells. Oncogene 21:6573\u20136586","journal-title":"Oncogene"},{"key":"604_CR207","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1158\/0008-5472.CAN-05-1681","volume":"66","author":"I Tirapu","year":"2006","unstructured":"Tirapu I, Huarte E, Guiducci C et al (2006) Low surface expression of B7\u20131 (CD80) is an immunoescape mechanism of colon carcinoma. Cancer Res 66:2442\u20132450","journal-title":"Cancer Res"},{"key":"604_CR208","first-page":"2339","volume":"18","author":"ZQ Toh","year":"2017","unstructured":"Toh ZQ, Licciardi PV, Russell FM et al (2017) Cervical cancer prevention through HPV vaccination in low- and middle-income countries in Asia. Asian Pacific J Cancer Prev 18:2339\u20132343","journal-title":"Asian Pacific J Cancer Prev"},{"key":"604_CR209","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1084\/jem.176.5.1453","volume":"176","author":"C Traversari","year":"1992","unstructured":"Traversari C, van der Bruggen P, Luescher I et al (1992) A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J Exp Med 176:1453\u20131457","journal-title":"J Exp Med"},{"key":"604_CR210","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/S0140-6736(15)00239-1","volume":"386","author":"CL Trimble","year":"2015","unstructured":"Trimble CL, Morrow MP, Kraynyak KA et al (2015) Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2\/3: a randomised, double-blind, placebo-controlled phase 2b trial. Lancet 386:2078\u20132088","journal-title":"Lancet"},{"key":"604_CR211","doi-asserted-by":"crossref","first-page":"129064","DOI":"10.1155\/2014\/129064","volume":"2014","author":"KE Uleberg","year":"2014","unstructured":"Uleberg KE, Ovestad IT, Munk AC et al (2014) Prediction of spontaneous regression of cervical intraepithelial neoplasia lesions grades 2 and 3 by proteomic analysis. Int J Proteomics 2014:129064","journal-title":"Int J Proteomics"},{"key":"604_CR212","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-00530-6","author":"J Varad\u00e9","year":"2020","unstructured":"Varad\u00e9 J, Magad\u00e1n S, Gonz\u00e1lez-Fern\u00e1ndez A (2020) Human immunology and immunotherapy: main achievements and challenges. Cell Mol Immunol. https:\/\/doi.org\/10.1038\/s41423-020-00530-6","journal-title":"Cell Mol Immunol"},{"issue":"Suppl 4","key":"604_CR213","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1634\/theoncologist.2010-S4-05","volume":"15","author":"AP Venook","year":"2010","unstructured":"Venook AP, Papandreou C, Furuse J et al (2010) The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist 15(Suppl 4):5\u201313","journal-title":"Oncologist"},{"key":"604_CR214","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.coviro.2017.03.014","volume":"23","author":"CM Walker","year":"2017","unstructured":"Walker CM (2017) Designing an HCV vaccine: a unique convergence of prevention and therapy? Curr Opin Virol 23:113\u2013119","journal-title":"Curr Opin Virol"},{"key":"604_CR215","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1158\/1940-6207.CAPR-17-0108","volume":"10","author":"J Wang","year":"2017","unstructured":"Wang J, Xie T, Wang B et al (2017) PD-1 blockade prevents the development and progression of carcinogen-induced oral premalignant lesions. Cancer Prev Res 10:684\u2013693","journal-title":"Cancer Prev Res"},{"key":"604_CR216","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1200\/JCO.2014.56.2595","volume":"32","author":"F W\u00e4rnberg","year":"2014","unstructured":"W\u00e4rnberg F, Garmo H, Emdin S et al (2014) Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS trial. J Clin Oncol 32:3613\u20133618","journal-title":"J Clin Oncol"},{"issue":"1 Pt 1","key":"604_CR217","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1158\/1078-0432.CCR-0647-3","volume":"10","author":"VA Westbrook","year":"2004","unstructured":"Westbrook VA, Schoppee PD, Diekman AB et al (2004) Genomic organization, incidence, and localization of the SPAN-x family of cancer-testis antigens in melanoma tumors and cell lines. Clin Cancer Res 10(1 Pt 1):101\u2013112","journal-title":"Clin Cancer Res"},{"key":"604_CR218","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1056\/NEJM200006153422401","volume":"342","author":"SJ Winawer","year":"2000","unstructured":"Winawer SJ, Stewart ET, Zauber AG et al (2000) A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. N Engl J Med 342:1766\u20131772","journal-title":"N Engl J Med"},{"key":"604_CR219","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10549-013-2813-6","volume":"143","author":"JS Wong","year":"2014","unstructured":"Wong JS, Chen YH, Gadd MA et al (2014) Eight-year update of a prospective study of wide excision alone for small low- or intermediate-grade ductal carcinoma in situ (DCIS). Breast Cancer Res Treat 143:343\u2013350","journal-title":"Breast Cancer Res Treat"},{"key":"604_CR220","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.canlet.2013.07.038","volume":"340","author":"X Wu","year":"2013","unstructured":"Wu X, Peng M, Huang B et al (2013) Immune microenvironment profiles of tumor immune equilibrium and immune escape states of mouse sarcoma. Cancer Lett 340:124\u2013133","journal-title":"Cancer Lett"},{"key":"604_CR221","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.oraloncology.2017.03.006","volume":"68","author":"T Yagyuu","year":"2017","unstructured":"Yagyuu T, Hatakeyama K, Imada M et al (2017) Programmed death ligand 1 (PD-L1) expression and tumor microenvironment: Implications for patients with oral precancerous lesions. Oral Oncol 68:36\u201343","journal-title":"Oral Oncol"},{"key":"604_CR222","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1054\/ijom.2002.0331","volume":"32","author":"CJ Yeh","year":"2003","unstructured":"Yeh CJ (2003) Treatment of verrucous hyperplasia and verrucous carcinoma by shave excision and simple cryosurgery. Int J Oral Maxillofac Surg 32:280\u2013283","journal-title":"Int J Oral Maxillofac Surg"},{"key":"604_CR223","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1073\/pnas.79.6.2031","volume":"79","author":"M Yoshida","year":"1982","unstructured":"Yoshida M, Miyoshi I, Hinuma Y (1982) Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 79:2031\u20132035","journal-title":"Proc Natl Acad Sci USA"},{"key":"604_CR224","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1600-0463.2008.00879.x","volume":"116","author":"A Yuan","year":"2008","unstructured":"Yuan A, Steigen SE, Goll R et al (2008) Dendritic cell infiltration pattern along the colorectal adenoma-carcinoma sequence. APMIS 116:445\u2013456","journal-title":"APMIS"},{"key":"604_CR225","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.3892\/ol.2017.6274","volume":"14","author":"DPXZD YuChengLiu","year":"2017","unstructured":"YuChengLiu DPXZD et al (2017) Comparative beneficiary effects of immunotherapy against chemotherapy in patients with advanced NSCLC: meta-analysis and systematic review. Oncol Lett 14:1568\u20131580","journal-title":"Oncol Lett"},{"key":"604_CR226","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S1079-2104(96)80303-9","volume":"82","author":"JM Zakrzewska","year":"1996","unstructured":"Zakrzewska JM, LopesSpeight VP et al (1996) Proliferative verrucous leukoplakia: a report of ten cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 82:396\u2013401","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"604_CR227","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.1158\/0008-5472.CAN-05-4081","volume":"66","author":"L Zhan","year":"2006","unstructured":"Zhan L, Xiang B, Muthuswamy SK (2006) Controlled activation of ErbB1\/ErbB2 heterodimers promote invasion of three-dimensional organized epithelia in an ErbB1-dependent manner: implications for progression of ErbB2-overexpressing tumors. Cancer Res 66:5201\u20135208","journal-title":"Cancer Res"},{"key":"604_CR228","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12967-017-1378-2","volume":"16","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Niu C, Cui J (2018) Gamma-delta (\u03b3\u03b4) T cells: friend or foe in cancer development? J Transl Med 16:3","journal-title":"J Transl Med"},{"key":"604_CR229","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.bbmt.2014.11.001","volume":"216","author":"J Zilberberg","year":"2015","unstructured":"Zilberberg J, Feinman R, Korngold R (2015) Strategies for the identification of T cell-recognized tumor antigens in hematological malignancies for improved graft-versus-tumor responses after allogeneic blood and marrow transplantation. Biol Blood Marrow Transplant 216:1000\u20131007","journal-title":"Biol Blood Marrow Transplant"},{"key":"604_CR230","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/2281056a0","volume":"228","author":"H zur Hausen","year":"1970","unstructured":"zur Hausen H, Schulte-Holthausen H, Klein G et al (1970) EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 228:1056\u20131058","journal-title":"Nature"}],"container-title":["Archivum Immunologiae et Therapiae Experimentalis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-021-00604-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00005-021-00604-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-021-00604-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T20:49:37Z","timestamp":1704228577000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00005-021-00604-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,27]]},"references-count":230,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["604"],"URL":"https:\/\/doi.org\/10.1007\/s00005-021-00604-x","relation":{},"ISSN":["0004-069X","1661-4917"],"issn-type":[{"value":"0004-069X","type":"print"},{"value":"1661-4917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,27]]},"assertion":[{"value":"5 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"3"}}